Credit Suisse’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $729K | Buy |
19,361
+1,051
| +6% | +$39.6K | ﹤0.01% | 2447 |
|
|
2023
Q4 | $196K | Buy |
18,310
+2,595
| +17% | +$27.8K | ﹤0.01% | 2979 |
|
|
2023
Q3 | $158K | Sell |
15,715
-184
| -1% | -$1.86K | ﹤0.01% | 3055 |
|
|
2023
Q2 | $189K | Buy |
+15,899
| New | +$189K | ﹤0.01% | 3087 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | -$13 | – | 3496 |
|
|
2022
Q4 | $13 | Sell |
1
-93
| -99% | -$1.21K | ﹤0.01% | 3685 |
|
|
2022
Q3 | $1K | Buy |
94
+77
| +453% | +$819 | ﹤0.01% | 3852 |
|
|
2022
Q2 | $0 | Buy |
+17
| New | – | ﹤0.01% | 4106 |
|